RecruitingNot ApplicableNCT07552116

Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia

Impact of Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia


Sponsor

Badr University

Enrollment

40 participants

Start Date

Apr 6, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.


Eligibility

Min Age: 3 YearsMax Age: 5 Years

Inclusion Criteria3

  • Dawn Syndrome children with pneumonia
  • Mean age of 3.73±1.82 year
  • Children were in the first attack of bronchopneumonia.

Exclusion Criteria1

  • Other chest disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERlow intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements

low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements

OTHERreceived inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.

received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.


Locations(1)

Mona Mohamed Abdelkhalek

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07552116


Related Trials